Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25784691 | 1.00 | TRPA1 (0.39) | TRPA1TRPM8ABCB1MAPK1NPSR1 | |
| SCHEMBL25784701 | 1.00 | TRPA1 (0.39) | TRPA1TRPM8ABCB1MAPK1NPSR1 | |
| SCHEMBL13790042 | 1.00 | TRPA1 (0.39) | TRPA1TRPM8ABCB1MAPK1NPSR1 | |
| SCHEMBL25250848 | 1.00 | TRPA1 (0.39) | TRPA1TRPM8ABCB1MAPK1NPSR1 | |
| SCHEMBL2698895 | 1.00 | TRPA1 (0.39) | TRPA1TRPM8ABCB1MAPK1NPSR1 | |
| SCHEMBL25784634 | 0.79 | ABCB1 (0.35) | ABCB1 | |
| SCHEMBL25784801 | 0.75 | TRPA1 (0.42) | TRPA1TRPM8ABCB1 | |
| SCHEMBL21333786 | 0.73 | TRPA1 (0.32) | TRPA1TRPM8 | |
| SCHEMBL8428196 | 0.68 | CA1 (0.33) | — | |
| SCHEMBL20863050 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. | 2023-06-29 | — | — | US | disclosed |
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. | 2023-06-29 | — | — | US | disclosed |
| WO-2023122724-A1 | IMPROVED SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023122724-A1 | IMPROVED SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | FDFT1, DLST, PCMT1 | TRPA1 677/4885TRPM8 1032/4885ABCB1 4768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.